1 The activities of a range of agonists at D 2(long) dopamine receptors expressed in CHO cells have been determined in ligand binding and in a functional assay, the stimulation of [
Introduction
Five subtypes of dopamine receptor have been identi®ed (D 1 ± D 5 ) and these may be divided into two subfamilies (the D 1-like receptors (D 1 , D 5 ) and the D 2-like receptors (D 2 , D 3 , D 4 )) on the basis of DNA sequence and functional properties (Sibley & Monsma, 1992; Civelli et al., 1993; Neve & Neve, 1997) . The dopamine receptors all signal via coupling to G-proteins and the members of the D 2-like subfamily have all been shown to inhibit adenylyl cyclase when expressed in Chinese hamster ovary (CHO) cells (Chio et al., 1994; Gardner et al., 1996) although linkage to other second messenger responses has also been observed in other systems (Vallar & Meldolesi, 1989) . The D 2-like receptors also exist in variant forms e.g. the D 2(short) and D 2(long) receptors generated by alternative splicing of a common gene. These isoforms may have small dierences in their abilities to bind drugs (Castro & Strange, 1993; Malmberg et al., 1993) and they may also signal via dierent G-proteins (Montmayeur et al., 1993; Senogles, 1994) , although the precise speci®city of these receptor/G-protein interactions has not been de®ned.
For G-protein linked receptors such as the dopamine receptors it is thought that an agonist binds to the receptor (R) to stabilize a form of the receptor (R*) that is able to couple to the G-protein Samama et al., 1993) . The agonist also stabilizes the receptor/G-protein complex (R*G) in the form of the ternary complex (AR*G). In the ternary complex guanosine 5'-diphosphate (GDP) attached to the G-protein is exchanged for guanosine 5'-triphosphate (GTP) and the ternary complex bearing GTP disintegrates to yield a and bg subunits of the G-protein that can in¯uence the activity of eector proteins. There is also some suggestion, based on the results of mutations, that the breakdown of the ternary complex may be regulated by agonists (Hausdor et al., 1990; Van Koppen et al., 1994) . Therefore the agonist may have three or more eects on the pathway from agonist binding to the agonist-mediated signal.
For receptors such as the D 2 dopamine receptor a spectrum of chemically dierent agonists exists and these can exhibit dierent potencies and extents of agonism, i.e. some can be full, some can be partial agonists, some can have a high potency, some low potency. In terms of understanding drug action it is important to understand the molecular basis of these dierences. Therefore, we have examined a range of agonists for their abilities to bind to the receptor and to stimulate [ 35 S]-guanosine-5'-O-(g-thiotriphosphate) binding, a functional test for receptor/G-protein coupling (Gardner et al., 1996) . We have used the human D 2(long) receptor expressed in CHO cells as a model system for these studies. We have previously obtained data on agonist eects at the D 2(short) dopamine receptor (Gardner et al., 1997) and a comparison between the two receptor isoforms can now be made using these assay systems.
Methods

Cell culture
CHO-D2L cells expressing the recombinant human D 2(long) dopamine receptor gene (Hayes et al., 1992) were grown in RPMI 1640 medium supplemented with 2 mM glutamine, 5% foetal bovine serum and 200 mg ml 71 active geneticin in an atmosphere of 5% CO 2 at 378C. Cells were passaged every 4 ± 5 days.
Preparation of cell membranes
The cells were grown to con¯uency in 175 cm 2¯a sks, the medium was removed, and the cells were washed with 10 ml of Buer A (20 mM HEPES, 6 mM MgCl 2 , 1 mM EDTA and 1 mM EGTA, pH 7.4) at 48C. The wash buer was removed and the cells were then scraped from the¯asks into 5 ml of buer A and homogenized with 30 strokes of a Dounce homogenizer. The homogenate was centrifuged at 1,700 g for 10 min at 48C and the resulting supernatant was centrifuged at 48,000 g for 1 h at 48C. The pellet from this centrifugation was resuspended in Buer A and again centrifuged at 48,000 g for 1 h at 48C. The resulting pellet was resuspended in Buer A at a concentration of 2 ± 3 mg protein ml 71 and stored at 7808C before use.
Radioligand binding assays
Cell membranes (25 ± 75 mg) were incubated with [ 3 H]-spiperone (0.3 nM for competition experiments, 40 pM to 2 nM in saturation experiments) and competing drugs in Buer B (20 mM HEPES, 10 mM MgCl 2 and 100 mM NaCl, pH 7.4 supplemented with 0.1 mM dithiothreitol) in a ®nal volume of 1 ml for 45 min at 258C. The assay was terminated by rapid ®ltration using a Brandel cell harvester and unbound radioligand removed with four washes of 4 ml of ice-cold phosphate buered saline (0.14 M NaCl, 3 mM KCl, 1.5 mM KH 2 PO 4 , 5 mM Na 2 HPO 4 , pH 7.4). Filters were soaked for at least 6 h in 2 ml LKB optiphase`Hisafe' 3 scintillation¯uid after which bound radioactivity was determined by liquid scintillation counting. Non-speci®c binding was de®ned in saturation and competition experiments in the presence of 3 mM (+)-butaclamol. In saturation experiments the total binding was determined in the presence of 3 mM (7)-butaclamol.
[
S]-GTPgS binding assays
The [
35 S]-GTPgS binding assay was carried out essentially as described by Gardner et al. (1996) . Cell membranes (25 ± 75 mg) were incubated in Buer B containing 0.1 mM dithiothreitol (DTT) and 1 mM GDP and drugs in a volume of 0.9 ml for 30 min at 308C. This preincubation ensured that the agonists tested were at equilibrium when the [ 35 S]-GTPgS (50 ± 150 pM, ®nal concentration) was added (in 100 ml of Buer B) to initiate the reaction. The assay mixture was incubated for a further 20 min unless otherwise stated. The assays were terminated by rapid ®ltration and bound radioactivity determined as described for the radio-ligand binding assays above. (Figure 1 , Table 1 ). Competition of apomorphine, dopamine, quinpirole, R(7)-10,11-dihydroxy-N-n-propylnoraporphine hydrochloride (NPA), talipexole, pergolide and ropinirole versus [ 3 H]-spiperone gave data that were best described by a two site model in the absence of added guanine nucleotides and the anities of the higher and lower anity sites (K h , K l ) were derived. However, in the presence of 100 mM GTP, the data were best described by a one site model. The anity of the lower anity site observed in the absence of GTP (K l ) and that of the single site observed in the presence of GTP (K i,GTP ) were similar. The % of the two classes of sites for these agonists was between about 25 and 50%. For dopamine and apomorphine, 100 mM GDP had a similar eect on the binding of these agonists to that seen with GTP. Table 1 .
Results
Ligand binding
For S(7)-3-(3-hydroxyphenyl)-N-propylpiperidine hydrochloride ((7)-3-PPP) the competition curves in the absence and presence of GTP were best described by a one site model although there was a signi®cant decrease in the anity observed in the presence of 100 mM GTP (paired t test, P50.05). Competition curves for bromocriptine, dihydroergocristine (DHEC) and lisuride were best described by a one site model and there was no signi®cant eect of the addition of 100 mM GTP on the competition curves (P40.05).
Agonist stimulation of [ 35 S]-GTPgS binding
The stimulation of the rate of [
35 S]-GTPgS binding by agonists was investigated over a range of appropriate concentrations of test compound. From the concentration-eect curves ( Figure   2 ) the pEC 50 and maximal agonist responses were determined for the agonists tested ( Table 2 ). The Hill coecients for all the agonists (except (7)-3-PPP and DHEC did not signi®cantly dier from 1 (paired t test, P40.05). For DHEC and (7)-3- ]-spiperone in the absence and presence of GTP or GDP (100 mM) as described in the Methods section and the competition curves were analysed by non linear regression analysis to derive dissociation constants for the higher (K h ) and lower (K l ) anity states and the percentage of higher anity states (%R h ) where a two site model provided a better description of the data; single values of the dissociation constant (K l or K i,GTP ) are given where a one binding site model provides the better description. Data are mean+s.e.mean (n53) or mean+range (n=2). Table 2 . EC 50 values and maximal eects were determined and data are expressed as mean+s.e.mean for n observations (n53) or mean+range (n=2). *Signi®cantly dierent from the dopamine response (P<0.05).
PPP the response was small and variable and so it was dicult to measure Hill coecients accurately. Consequently all data were analysed with Hill coecients constrained to 1. The agonists dopamine, quinpirole, apomorphine and NPA gave similar maximal responses whereas for all other agonists signi®cantly smaller maximal responses were observed (P50.05) ( Table 2) .
Discussion
In this study we have examined the eects of a series of dopamine agonists at the D 2(long) dopamine receptor using ligand binding and a functional assay, the stimulation of [
35 S]-GTPgS binding. The aim of the experiments was to try to understand the mechanistic basis of agonist action in more detail. The results show that using these in vitro assays it is possible to make measurements of agonist anity, potency and maximal functional eect. However, no simple relationship was seen between the ability of an agonist to promote formation of the ternary complex (AR*G) and the maximal functional eect.
Currently the accepted view of agonist action at G-protein coupled receptors is summarized in the extended ternary complex model Samama et al., 1993) . In this model, in the absence of agonist, the receptor can exist in two forms R and R* and only the latter can couple to the Gprotein. Agonists bind preferentially to R* and thus stabilize this form of the receptor. Formation of the R*G complex is also stabilized by the agonist so that the net result of agonist action is to promote formation of the ternary complex AR*G. The agonist, therefore, has two eects to promote the formation of the ternary complex, on the stabilization of R* and the stabilization of R*G. Once the ternary complex has formed, exchange of GDP attached to the G-protein for GTP is facilitated and when GTP is bound the complex dissociates in to the a-and bg-subunits of the G-protein which can then alter the activities of eector molecules. There is some evidence that as well as promoting the formation of the ternary complex the agonist promotes its breakdown (Hausdor et al., 1990; Birnbaumer et al., 1990; Van Koppen et al., 1994) , so that there may be three places in this series of events where the agonist can act.
Dierent aspects of this series of events may be assayed in order to understand how agonists act. In ligand binding assays agonists are thought to bind with higher anity to the receptor coupled to G-protein than to the uncoupled receptor (Wregget & De Lean, 1984; Lefkowitz et al., 1993) . This can lead in agonist/ 3 H-antagonist competition experiments to complexity in agonist binding which may be interpreted in terms of higher and lower anity binding states. These higher and lower anity states cannot be directly equated with the coupled and uncoupled receptors (Wregget & De Lean, 1984; Lee et al., 1986) although the ratio of the two anities is a measure of the stabilization of the ternary complex by the agonist. The guanine nucleotide exchange event may be assayed using the binding of [ (Gardner et al., 1996) . This assay provides a measure of the rate of GDP/GTP exchange which should be related to the overall functional response in the system.
S]-GTPgS
In the present experiments we have used ligand binding assays versus [
3 H]-spiperone to determine the properties of a series of agonists at human D 2(long) dopamine receptors expressed in CHO cells. For many of the agonists (apomorphine, dopamine, NPA, pergolide, quinpirole, ropinirole, talipexole) competition curves could be resolved in to contributions from higher (K h ) and lower (K l ) anity sites and in the presence of GTP a single class of sites was seen with an anity (K i,GTP ) similar to that seen for the lower anity population in the absence of GTP (K l ). As Lee et al. (1986) have suggested this pattern is consistent with a situation where there is an excess of receptor over G-protein, in which case the value for K l (K i,GTP ) corresponds to the anity of agonist for the receptor uncoupled from G-protein. However, for other agonists (bromocriptine, DHEC, lisuride, 3-PPP), a single binding site model provided a good description of data in the absence or presence of GTP and in some cases the anity was reduced signi®cantly by GTP (3-PPP) and in other cases it was not. For two agonists, apomorphine and dopamine, GDP was found to have similar eects to GTP. Whereas GTP is thought to lead to breakdown of the ternary complex, GDP probably sequesters G-protein a-subunits preventing ternary complex formation, the net result in either case being low anity agonist binding to the free receptor.
A functional measure of agonist action was obtained using the stimulation of [ 35 S]-GTPgS binding and this provided data on the maximal eect of the agonist as well as the potency. A spectrum of maximal activities was seen from partial to full agonists and the rank order of the values obtained was generally in agreement with data obtained in other functional assays (see for example McDonald et al., 1984; Meller et al., 1991) . However, there was no relationship between maximal eect and potency, with some agonists being very potent but only producing a partial eect, e.g. lisuride, but others producing a high maximal eect but with rather lower potency, e.g. quinpirole. Figure 3 Relations between ecacy parameters for agonists at D 2(long) dopamine receptors. The graphs show the relation between the K iGTP /K h ratio for the agonists tested and their maximal eect (a) and ampli®cation ratio (b) as given in Table 3 . The ternary complex model discussed above predicts that the complexity seen in agonist binding experiments should relate to agonist ecacy in some way. In the present experiments the complexity in agonist binding is manifest in the higher and lower anities seen for some agonists when they are used to inhibit [ 3 H]-spiperone binding and data are analysed in terms of two independent sites. It has been shown that the ratio of the anities (K i,GTP /K h , see above) is a measure of the stabilization of the ternary complex by the agonist and this should correlate to agonist ecacy (De Lean et al., 1980; Wregget & De Lean, 1984; Samama et al., 1993; Kenakin, 1993) . For D 2 dopamine receptors, Lahti et al. (1992) and Harley et al. (1995) tested this idea and determined a K i,GTP /K h ratio and in both studies a correlation was claimed between this ratio and agonist ecacy (maximal agonist eect and relative agonist ecacy respectively). The method for determining the K i,GTP /K h ratio was slightly dierent from that used here and involved agonist competition experiments versus a tritiated agonist in the absence of added guanine nucleotides (K h ), and versus a tritiated antagonist in the presence of GTP (K i,GTP ). There were also ionic dierences in the buers used for the two determinations. There is no theoretical basis for making these determinations under dierent conditions and the method resulted in values less than one for some agonists. Also Lahti et al. (1992) normalized their data for full agonists to take account of the fact that these gave dierent K i,GTP /K h ratios. O'Boyle & Lawlor (1996) used a similar method for determining K i,GTP /K h to that used in the present study together with the normalized ecacy data of Lahti et al. (1992) and although a correlation was obtained this included four agonists with K i,GTP /K h ratios of unity.
a b
In the present experiments we have sought correlations between the K i,GTP /K h ratio and measures of agonist ecacy such as the maximal agonist eect in the functional assay, stimulation of [ (Figure 3 ) and the agonists may be divided in to two sub-groups as follows. In the ®rst sub-group the agonists show a high K i,GTP /K h ratio (4*40) and there is a high maximal agonist eect (64% or more of the dopamine eect). It seems that if the ternary complex is well stabilized then a high maximal agonist eect is observed and although there is a tendency for higher values of K i,GTP /K h to be associated with higher maximal agonist activity and lower values with lower activity, no clear correlation is seen between the two quantities. This lack of correlation implies that there is further complexity in the system. We have described a similar lack of correlation but with less extensive data for the D 2(short) dopamine receptor (Gardner et al., 1997) . In the second sub-group the agonists show K i,GTP /K h ratios close to one and these compounds are partial agonists. In this sub-group, therefore, agonism may be achieved in the absence of apparent stabilization of the ternary complex.
The lack of correlation between the ability of the agonist to stabilize the ternary complex and the maximal agonist eect implies additional complexity and this may reside in the models of agonism outlined earlier. The extended ternary complex model proposes that agonists may in¯uence ecacy at two stages, stabilization of R* over R, and stabilization of R*G over R*. The binding of an agonist to the receptor in the absence of G-protein coupling (K i,GTP ) will lead to stabilization of R* to an extent that depends on the dierent anities of the agonist for R and R*, but the apparent anity of the agonist will be between the anity for R and R*. Thus the K i,GTP values determined in the present study will not be an accurate estimate of the anity for R unless there is little stabilization of R*, and this is unlikely except for the very poor agonists. Therefore estimates of stabilization of ternary complex formation based on the simple K i,GTP /K h ratio may underestimate stabilization at the R*/R step. It is presently impossible to quantify this stabilization.
The ergolines and ergopeptines (bromocriptine, DHEC and lisuride) may be extreme examples of this eect. These compounds are agonists but exhibit no apparent stabilization of the ternary complex based on K i,GTP /K h ratios. Similar observations have been made before for the D 2 dopamine receptor and 5-HT 1A (5-hydroxytryptamine) receptor (Sibley & Creese, 1983; Sundaram et al., 1995; Gardner et al., 1997) . For these compounds binding to the receptor in the absence of Gprotein coupling may strongly stabilize the activated form of the receptor (AR*) and there may be little energy gained in ternary complex (AR*G) formation, ie AR* is close in structure to AR*G. This would give agonism but there would be no dierence between binding anities in the absence and presence of GTP as described here. For these compounds the binding energy between receptor and ligand is fully expressed upon binding to the free receptor.
It would be useful to estimate the degree of ampli®cation (the extent to which potency for an agonist in a functional assay is greater than its anity for binding to the receptor) for dierent agonists as this is another important part of agonist ecacy. Indeed for full agonists this may be more informative than the maximal eect in probing ecacy, as depending on Table 3 Comparison of agonist binding and functional parameters on D 2(short) and D 2(long) dopamine receptors (the ratio of apparent dissociation constants in agonist binding assays in the absence of added guanine nucleotides) and the ampli®cation ratio, (K i,GTP /EC 50 ). These parameters are discussed in more detail in Gardner et al. (1997) and the data for D 2(short) are taken from Gardner et al. (1997) .
the system there may be a ceiling on the maximal agonist eect possible but agonists may still dier in their degree of ampli®cation. In experiments on the D 2(short) dopamine receptor we showed that the ampli®cation ratio could be estimated from the K i,GTP /EC 50 ratio (Gardner et al., 1997) and these data are given together with data for the D 2(long) receptor in Table 3 . It might be expected that the ampli®cation ratio would be related at least in part to the ability of the agonist to stabilize the ternary complex (K i,GTP /K h ). There is a slight tendency for a higher value of K i,GTP /K h to be associated with a high ampli®cation ratio (Figure 3 ) and a lower value with a low ampli®cation ratio but there are many exceptions. Notable here are apomorphine and NPA which appear to stabilize the ternary complex well but provide a low ampli®cation ratio. At the D 2(short) dopamine receptor similar ®ndings were obtained for apomorphine (Gardner et al., 1996) . A possible explanation for these ®ndings is that these compounds stabilize the ternary complex well, but that for these compounds breakdown of the ternary complex occurs poorly. This would be consistent with the observations of Birnbaumer et al. (1990) , Hausdor et al. (1990) and Van Koppen et al. (1994) indicating that ternary complex breakdown is an event regulated by agonists and can be rate determining. Alternatively, it is possible that for these compounds guanine nucleotide (GDP/GTP) exchange is slow.
The ternary complex models discussed here may also be incomplete (see for example Lee et al., 1986) and this may lead to some of the discrepancies highlighted in the present study. It has been proposed that there may not be free diusion of receptors and G-proteins in the plane of the membrane (Wreggett, 1987; Neubig et al., 1988) . Also it has been suggested that receptors and G-proteins may exist as heteroligomers (Jahangeer & Rodbell, 1993; Sinkins & Wells, 1993; Wreggett & Wells, 1995) and models to describe such behaviour have been outlined. For the b 2 -adrenoceptor (Hebert et al., 1996) and the D 2 dopamine receptor (Ng et al., 1996) there is some evidence that the receptors may exist as dimers, although these observations require further validation.
It is also of some interest to compare agonist actions at the two isoforms of the D 2 receptor, D 2(short) and D 2(long) , as these have been shown to couple to eectors via dierent G-proteins (Montmayeur et al., 1993; Senogles, 1994) and this may lead to dierent agonist ecacy patterns. Data for several agonists are given in Table 3 for the two isoforms. Whereas binding anities at the two receptors are very similar for the low anity state and maximal agonist eects are similar, there are signi®cant dierences where measures of agonist ampli®cation are concerned. In particular there are dierences in the rank orders for the ampli®cation ratios for the set of agonists tested on the two receptors. This suggests that for the two isoforms of the D 2 receptor there is some dierence in the activation process. This could re¯ect the coupling of the two isoforms to dierent G-proteins as has been suggested from some experimental work (Montmayeur et al., 1993; Senogles, 1994) . This would then represent a form of agonist tracking whereby the particular receptor/G-protein combination exhibits a particular ampli®cation-ratio-pattern for a range of agonists. It may be possible, therefore, to use the ampli®ca-tion-ratio-pattern in functional in vivo tests to identify the contribution of receptor isoforms.
In conclusion, the data presented here show that it is possible to obtain measures of agonist binding and ecacy at D 2 dopamine receptors using simple in vitro tests. Dierences in agonist ecacy patterns may be apparent for dierent receptor isoforms.
